Axillary lymph node burden(ALNB) is a critical factor in determining treatment strategies for clinical T1–T2 (cT1–T2) stage breast cancer. However, as ALNB assessment relies on invasive procedures, exploring non‐invasive methods… Click to show full abstract
Axillary lymph node burden(ALNB) is a critical factor in determining treatment strategies for clinical T1–T2 (cT1–T2) stage breast cancer. However, as ALNB assessment relies on invasive procedures, exploring non‐invasive methods is essential.
               
Click one of the above tabs to view related content.